Prentice Wealth Management LLC Cel Sci Corp Transaction History

Prentice Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$7.64 - $12.49 $229 - $374	-30 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$8.68 - $27.49 $130 - $412	-15 Reduced 33.33%	30 $1,000
Q1 2021 Jun 17, 2021	SELL	$12.0 - $27.64 $7,668 - $17,661	-639 Reduced 93.42%	45 $1,000
Q1 2021 Jun 08, 2021	BUY	$12.0 - $27.64 $8,208 - $18,905	684 New	684 $1,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Prentice Wealth Management LLC with notifications on news.